Haemophilus influenzae type b meningitis

In adults and children with meningitis caused by Haemophilus influenzae type b (Hib), drug choice depends on whether susceptibility to benzylpenicillin has been confirmed and whether the patient is hypersensitive to penicillins. When Hib infection has been confirmed:

  • start directed therapy (see regimens below)
  • continue dexamethasone therapy for a total of 4 days (empiric + directed)
  • consider whether clearance antibiotics for close contacts are required
  • report the case of Haemophilus influenzae type b infection to the local public health authority because it is a notifiable condition12
  • give age-appropriate catch-up Hib vaccination, after recovery, in patients younger than 5 years who have not been fully vaccinated – see the Australian Immunisation Handbook.

For the treatment of meningitis caused by Hib in adults and children, use:

1ceftriaxone 2 g (child 1 month or older: 50 mg/kg up to 2 g) intravenously, 12-hourly for 7 days 3 ceftriaxone ceftriaxone ceftriaxone

OR

1cefotaxime 2 g (child: 50 mg/kg up to 2 g) intravenously, 6-hourly for 7 days. For dosage adjustment in adults with kidney impairment, see cefotaxime dosage adjustment cefotaxime cefotaxime cefotaxime

PLUS

dexamethasone 10 mg (child: 0.15 mg/kg up to 10 mg) intravenously, preferably starting before the first dose of antibiotic, then 6-hourly for a total of 4 days (empiric + directed therapy). dexamethasone dexamethasone dexamethasone

If susceptibility to benzylpenicillin is confirmed, de-escalate therapy and use:

benzylpenicillin 2.4 g (child: 60 mg/kg up to 2.4 g) intravenously, 4-hourly for 7 days. For dosage adjustment in adults with kidney impairment, see benzylpenicillin dosage adjustment benzylpenicillin benzylpenicillin benzylpenicillin

PLUS

dexamethasone 10 mg (child: 0.15 mg/kg up to 10 mg) intravenously, preferably starting before the first dose of antibiotic, then 6-hourly for a total of 4 days (empiric + directed therapy). dexamethasone dexamethasone dexamethasone

Clearance antibiotics for Hib infection are required if the patient was treated with benzylpenicillin alone, because it does not reliably clear nasopharyngeal carriage.

For adults and children who have had a nonsevere (immediate or delayed) or severe immediate4 hypersensitivity reaction to a penicillin, use ceftriaxone or cefotaxime (see dosages above).

For adults and children who have had a severe delayed5 hypersensitivity reaction to a penicillin, use:

ciprofloxacin 400 mg (child: 10 mg/kg up to 400 mg) intravenously, 8-hourly for 7 days6. For dosage adjustment in adults with kidney impairment, see ciprofloxacin intravenous dosage adjustment ciprofloxacin ciprofloxacin ciprofloxacin

PLUS

dexamethasone 10 mg (child: 0.15 mg/kg up to 10 mg) intravenously, preferably starting before the first dose of antibiotic, then 6-hourly for a total of 4 days (empiric + directed therapy). dexamethasone dexamethasone dexamethasone

1 For Australian national notifiable diseases and case definitions, see the Communicable Diseases Network Australia (CDNA) website.Return
2 Contact details for Australian state and territory government health departments and public health units are available here.Return
3 In children, a single daily dose of ceftriaxone (100 mg/kg up to 4 g intravenously, daily) is used in some centres. A single daily dose of ceftriaxone may also be used when patients complete their course of treatment at home in an ambulatory antimicrobial therapy program.Return
4 Severe immediate hypersensitivity reactions include anaphylaxis, compromised airway, airway angioedema, hypotension and collapse.Return
5 Severe delayed hypersensitivity reactions include cutaneous adverse drug reactions (eg drug rash with eosinophilia and systemic symptoms [DRESS], Stevens–Johnson syndrome/toxic epidermal necrolysis [SJS/TEN], severe blistering or desquamative rash), and significant internal organ involvement (eg acute interstitial nephritis).Return
6 Ciprofloxacin is not licensed for use in children on the basis of animal studies that showed an adverse effect on cartilage development with quinolone use; however, clinical trial data suggest that adverse musculoskeletal events are usually mild and short term, similar to those observed in adults. Ciprofloxacin can be used in children when it is the drug of choice.Return